Hutchison China Meditech Ltd. announced that 2007 revenues increased 29% to $65.1 million, but its net loss also moved higher, rising from $10 million to $17.2 million. The company said the majority of the loss came from higher research expenses. The net loss also includes a non-recurring charge of $5.1 million for discontinuing its Nao Ling Tong product line. More details...

Stock Symbols: (AIM: HCM) (NYSE: LLY)